Endo Launches PREVDUO™, the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled Syringe

Endo International has released PREVDUO, a pre-filled syringe that combines neostigmine methylsulfate and glycopyrrolate injection. This product is the first and only FDA-approved neostigmine-glycopyrrolate combination available in the US. The two ingredients have both been approved as single active ingredient drug products. By eliminating the need for two discrete syringe preparations and admin..